After showing early potential, cholesterol medication fenofibrate fails to cut severe symptoms or death miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.
A new international multi-institutional study led by scientists from Penn Medicine has found that fenofibrate was unable to reduce the severity of disease or prevent adverse outcomes such as deaths in COVID-19 patients.
Fenofibrate Fails to Prevent Severe Covid Outcomes miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.